Fertility House Calls connects women and couples with personalized fertility care from the comfort of their own home. Service designed…
Interim analysis of the Phase 3 PUNCH™ CD3-Open-Label Study (OLS) showed positive efficacy and consistent safety with RBX2660 for up…
RBX2660 pivotal Phase 3 trial successfully met the primary endpoint; data presented today at Digestive Disease Week® (DDW) RBX2660 is…
For the first time ever, Ferring and Rebiotix, a Ferring Company, will present landmark Phase 3 efficacy and safety data…
Teigen alongside RESOLVE: The National Infertility Association and Ferring Pharmaceuticals aim to change and amplify the fertility conversation by launching…
Parsippany, NJ – December 18, 2020 – Beginning January 1, 2021, Ferring Pharmaceuticals will gain preferred access through CVS Health…
CDC defines Clostridioides difficile (C. diff) infection as a significant healthcare burden to patients and physicians, labeling C. diff as…
Ferring and Rebiotix, a Ferring Company, will present two oral abstracts describing translational studies of investigational microbiome-based therapeutics RBX2660 and…
Ferring will deliver 11 presentations at the virtual congress; including six oral presentations The new data being presented further underscores…
FOR IMMEDIATE RELEASE – Parsippany, NJ – August 5, 2020– Ferring Pharmaceuticals US is voluntarily recalling all lots on the…